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Edited by Jesus AvilaAbstract Hyperphosphorylation of tau is of fundamental
importance for neuroﬁbrillary lesion development in Alzheimers
disease, but the mechanisms through which it acts are not clear.
Experiments with pseudophosphorylation mutants of full-length
tau protein indicate that incorporation of negative charge into
speciﬁc sites can modulate the aggregation reaction, and that
this occurs by altering the critical concentration of assembly.
Here, the kinetic origin of this eﬀect was determined using quan-
titative electron microscopy methods and pseudophosphorylation
mutant T212E in a full-length four-repeat tau background. On
the basis of disaggregation rates, decreases in critical concentra-
tion resulted primarily from decreases in the dissociation rate
constant. The results suggest a mechanism through which site-
speciﬁc posttranslational modiﬁcations can modulate ﬁlament
accumulation at low free intracellular tau concentrations.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Alzheimers disease (AD) andother tauopathic neurodegener-
ative diseases are characterized in part by the intraneuronal
accumulation of ﬁlaments composed of the microtubule-
associated protein tau [1]. Filament formation correlates with
neurodegeneration and cognitive decline, and thus is closely
linked with clinical endpoints of disease [2,3]. Because of this
linkage, there is great interest in identifying key factors regulat-
ing the tau aggregation pathway. Posttranslational modiﬁca-
tions are leading candidates for carrying out this role. In brain
tissue undergoing tauopathic neurodegeneration, a portion of
tau becomes hyperphosphorylated, with ﬁlamentous tau con-
taining 3–4-fold higher stoichiometries of phosphate than tau
isolated from normal brains [4,5]. Phosphorylation on certain
sites decreases the aﬃnity of tau for microtubules, fosteringAbbreviations: AD, Alzheimers disease; C18H37SO4Na, sodium
octadecyl sulfate; DMSO, dimethylsulfoxide; N744, 3-(2-hydroxy-
ethyl)-2-[2-[[3-(2-hydroxyethyl)-5-methoxy-2-benzothiazolylidene]met-
hyl]-1-butenyl]-5-methoxybenzothiazolium; PHF, paired-helical
ﬁlament; TEM, transmission electron microscopy
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of aggregation [6,7]. Thus, phosphorylation has been postulated
to be a key initiating event in the tau aggregation pathway.With
respect to the aggregation reaction itself, however, the eﬀects of
phosphorylation are contentious. In vivo, phosphorylation of
fetal tau at similar sites [8,9] and nearly the same stoichiometry
[10] as ﬁlamentous-tau does not trigger ﬁbrillization. In vitro,
phosphorylating conditions can promote [11] or inhibit [12]
tau aggregation depending on experimental conditions, sample
purity, assay format, sitesmodiﬁed, and source of phosphorylat-
ing activity. To overcome the ambiguity associated with phos-
phorylation reactions, and to extend resolution to the level of
individual phosphorylation sites, the incorporation of negative
charge inherent in phosphorylation has beenmimicked bymuta-
tion of hydroxyamino acids into negatively charged Asp or Glu
residues. These imitate phosphorylation-induced changes in the
structure and microtubule-binding function of tau [13–16] and
react with many phosphoepitope-selective antibodies [17]. At
physiological bulk tau concentrations (1–10 lM, [18]), full-
length recombinant tau pseudophosphorylated at certain sites
(e.g., residue 212) aggregates more eﬃciently than control sam-
ples, yielding greater ﬁlament mass at equilibrium, and lower
critical concentrations [19].
The critical concentration reﬂects post-nuclear equilibria
(i.e., the extension reaction, where protein molecules equili-
brate with ﬁlament ends), and is a characteristic feature of
nucleation–elongation reactions. It is deﬁned as [20]
Kcrit ¼ k=kþ; ð1Þ
where Kcrit is the critical concentration, and k and k+ are the
rate constants for protein monomer dissociation from and
association with ﬁlament ends, respectively, assuming a simple
single step binding model. The ability of pseudophosphoryla-
tion to lower critical concentration implies that it decreases
k, reﬂecting ﬁlament stabilization, or increases k+, reﬂecting
a more eﬃcient association reaction.
Here, we test this hypothesis using a pharmacological ap-
proach and length distribution measurements. Results indicate
that pseudophosphorylation acts primarily to stabilize ﬁla-
ments by slowing rates of dissociation.2. Materials and methods
2.1. Materials
Recombinant His-tagged wild-type htau40 and pseudophosphoryla-
tion mutant T212E were prepared as described previously [19,21].
Stock solutions of alkyl sulfate detergent sodium octadecyl sulfateblished by Elsevier B.V. All rights reserved.
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2-[2-[[3-(2-hydroxyethyl)-5-methoxy-2-benzothiazolylidene]methyl]-1-
butenyl]-5-methoxybenzothiazolium (N744) (Neuronautics, Evanston,
IL), and ThS (Sigma, St. Louis, MO) were prepared in 1:1 H2O/isopro-
panol, dimethylsulfoxide (DMSO), and water, respectively.
2.2. Tau aggregation assay
Tau preparations were incubated without agitation in assembly buf-
fer (10 mM HEPES, pH 7.4, 100 mM NaCl, 5 mM dithiothreitol) at
37 C for up to 24 h in the presence or absence of C18H37SO4Na indu-
cer. For transmission electron microscopy (TEM) analysis, aliquots
were removed, treated with 2% glutaraldehyde (ﬁnal concentration),
mounted on formvar/carbon-coated 300 mesh grids, and negatively
stained with 2% uranyl acetate as described previously [22,23].
2.3. Thioﬂavin S-ﬂuorescence assay
Tau was aggregated at 37 C for 24 h as described above except that
the reactions contained varying concentrations of ThS probe (2–
40 lM) and inhibitor N744 (0–5 lM). Equilibrium ﬂuorescence
(kex = 440 nm; kem = 495 nm) was then measured in a FlexStation plate
reader (Molecular Devices, Sunnyvale, CA) operated at sensitivity 10,
high PMT using black 96-well plates sealed with transparent foil. Fluo-
rescence data were analyzed in Hill plot format
log
Y
1 Y ¼ n log½N744 þ log IC50; ð2Þ
where Y is the ﬂuorescence in the presence of N744 expressed as a frac-
tion of the ﬂuorescence recorded in the absence of N744 and n is the
Hill coeﬃcient. IC50 values were determined from interpolated values
of N744 concentration at an ordinate value of zero after ﬁtting data
to a linear regression.
2.4. Tau disaggregation assay
Tau preparations (4 lM) were polymerized under standard condi-
tions as described above for 24 h, then divided into two separate tubes.
One tube received N744 at a ﬁnal concentration of 4 lM, whereas the
second tube received DMSO vehicle alone. Aliquots were removed
from each sample after 0, 1, 3, 5, 9, and 12 h incubation and subjected
to the TEM assay described above.
2.5. Analytical methods
Dissociation rate constants (k) were determined as described for
exponential length distributions [24,25]. Brieﬂy, disaggregation data
derived from TEM length measurements were ﬁt to an exponential de-
cay function [26]
y ¼ y0ekapp t; ð3Þ
where y is the ﬁlament length at time t, y0 is ﬁlament length at time
zero, and kapp is the pseudo-ﬁrst order rate constant for the process.
After solving for kapp, the initial velocity of disaggregation (dy/dt)
was determined from the ﬁrst derivative of the exponential decay func-
tion
dy=dt ¼ y0kapp: ð4Þ
Dissociation rate constants were extracted from initial velocities by
converting length into tau protomer units (assuming 1.5 tau mole-
cules/nm of straight ﬁlament, [27]) and then dividing by the number
of ﬁlaments measured at time zero (i.e., it was assumed that dissocia-
tion proceeded from only one end of each ﬁlament). Association rates
were then estimated from established critical concentration values [19]
and Eq. (1) assuming a two state model (i.e., all tau was either mono-
meric or incorporated into ﬁlaments).3. Results and discussion
3.1. Experimental approach
The strategy for estimating elementary rate constants
associated with the extension reaction rests on ﬁve principal
considerations. First is the use of puriﬁed recombinant full-length tau isoform htau40, which aggregates most eﬃciently
of the six naturally occurring full-length isoforms under
near-physiological conditions [28]. Within the htau40 back-
ground, pseudophosphorylation mutant htau40T212E was
chosen for analysis because it returns the largest change in
critical concentration of any phosphorylation mimicry mu-
tant studied to date [19], thereby assuring that diﬀerences
in aggregation rates would be large enough to measure. Sec-
ond is the use of an anionic surfactant to accelerate the
aggregation reaction. In the presence of alkyl sulfate deter-
gent C18H37SO4Na, htau40 ﬁlaments reach equilibrium and
adopt an exponential distribution of lengths well within
24 h [23]. In addition, the length distributions induced by
C18H37SO4Na are long relative to other inducers [23], there-
by simplifying and increasing the precision of counting
methods. Third is the use of TEM methods to assess ﬁbril-
lization time course. TEM-based measurements are linear
with ﬁlament concentration over the range used here, and
yield estimates of both total ﬁlament lengths and numbers
that are required for kinetic analysis [29]. Fourth is the
use of small-molecule inhibitor N744 to perturb the ﬁnal
tau aggregation equilibrium [26]. Because N744 raises the
critical concentration of assembly, its addition to an equilib-
rium population of ﬁlaments results in immediate initiation
of a time-dependent, endwise disaggregation [26] that at
early times depends on k and the concentration of ﬁlament
ends. Finally, because endwise disaggregation from exponen-
tial ﬁlament length distributions follows pseudo-ﬁrst order
kinetics [24], it is possible to measure apparent rate con-
stants and relate them to elementary rate constant k. An
estimate of association rate constant k+ is then obtained
from the measured critical concentration and Eq. (1). Be-
cause tau ﬁlaments remain associated with C18H37SO4Na in-
ducer through one end over the time periods examined here
[18], the analysis assumes all extension/disaggregation events
occur at the remaining free ﬁlament end.
3.2. N744 interacts similarly with both mutant and wild-type
tau preparations
Successful applicationof the strategy requires thatN744 inter-
act similarly with bothmutant and wild-type tau. Therefore, the
binding aﬃnity of N744 for both wild-type htau40 and
htau40T212E was estimated from ThS competition assays (ThS
is a ﬂuorescent probe for b-sheet structure). Increasing concen-
trations of N744 inhibited the ﬂuorescence associated with ThS
binding.As foundpreviously for inhibition of ﬁbrillization, inhi-
bition of ThS bindingwas cooperative with respect toN744 con-
centration for both htau40 (Hill coeﬃcient = 1.18 ± 0.03) and
htau40T212E (Hill coeﬃcient = 1.26 ± 0.31). Increasing concen-
trations of ThS probe produced a family of parallel lines shifted
toward higher IC50 values (Fig. 1). The overall pattern for both
htau40 and htau40T212E was consistent with competitive inhibi-
tion. Similar results were obtained for initial rates (data not
shown) and ﬁnal equilibrium (Fig. 1). In competitive binding
reactions, the relationship between inhibitor IC50 and itsKi is di-
rectly proportional to the concentration of probe (ThS) relative
to its EC50 [30]. Therefore,Ki values were estimated from the ab-
scissa intercepts of IC50 vs. ThS concentration replots (Fig. 2).
Values for htau40T212E mutant (162 ± 17 nM) and WT
(156 ± 18) were not signiﬁcantly diﬀerent at p < 0.01. These data
indicate that N744 interacts similarly with both mutant and
wild-type tau constructs.
Fig. 3. Timecourse of N744-mediated disaggregation. Filaments
prepared (24 h at 37 C) from wild-type htau40 or pseudophosphory-
lation mutant htau40T212E (each at 4 lM) and C18H37SO4Na inducer
(50 lM) were split into two equal pools and further incubated in the
presence of DMSO vehicle alone (s) or 4 lM N744 (d). Aliquots of
each reaction were stopped at 0, 1, 3, 5, 9, 12, and 19 h by the addition
of glutaraldehyde and ﬁlaments P 50 nm in length analyzed by the
quantitative TEM. Each data point represents total ﬁlament length per
ﬁeld ± S.D. (n = 5 observations) normalized to unity at time zero,
whereas each line represents best ﬁt of the data points to an
exponential decay function (Eq. (3)). Although total tau ﬁlament
length decreased slowly over time in the presence of DMSO vehicle
alone, the rate was substantially faster in the presence of N744.
Diﬀerences in net rates of disaggregation indicate that ﬁlaments
prepared from pseudophosphorylation mutant htau40T212E are signif-
icantly more stable than those prepared from wild-type htau40.
Fig. 1. N744 competes with ThS binding. Htau40 and
pseudophosphorylation mutant htau40T212E (4 lM) were incubated
(37 C) with C18H37SO4Na (50 lM) in the presence of 2 (d), 4 (s), 10
(j), 20 (h), 30 (m), or 40 (n) lM ThS probe and varying
concentrations (0, 0.13, 0.25, 0.5, 1, 2.5, and 5 lM) of inhibitor
N744, then subjected to ﬂuorescence spectroscopy (kex = 440 nm;
kem = 495 nm). Data points are presented in Hill plot format where
each solid line represents best ﬁt to a linear regression. The families of
shifting parallel lines indicate that N744 competes with ThS for
binding to both wild-type htau40 and pseudophosphorylation mutant
htau40T212E.
Fig. 2. N744 binds wild-type htau40 and pseudophosphorylation
mutant htau40T212E with similar aﬃnity. N744 IC50 values determined
from Hill plots in Fig. 1 were replotted vs. ThS concentration. Each
data point represents an IC50 determination at a given ThS concen-
tration, whereas each line represents the best ﬁt of the data points to a
linear regression. The Ki for competitive N744 binding (corresponding
to the extrapolated ordinate intercepts) did not diﬀer signiﬁcantly
(p < 0.01) for wild-type htau40 (d) and pseudophosphorylation
mutant htau40T212E (s), indicating that N744 interacted similarly
with each preparation.
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To determine the eﬀect of pseudophosphorylation on disag-
gregation, equilibrium populations of ﬁlaments prepared from
wild-type htau40 and htau40T212E were treated with N744
(4 lM) or DMSO vehicle alone and ﬁlament numbers and
lengths were measured over a 12 h ‘‘chase’’ by TEM. As ob-
served previously with htau40 and arachidonic acid inducer,
DMSO vehicle alone produced a small but signiﬁcant disaggre-
gation of both ﬁlament populations. In contrast, addition of
N744 in vehicle led to a more rapid decrease in total ﬁlament
length so that up to 60% of total ﬁlament length was lost over
the 12 h time course (Fig. 3). The net apparent pseudo-ﬁrst or-
der rate constant (kapp) for disaggregation of wild-type htau40
was 0.067 ± 0.008 h1. This value was smaller than previouslyreported for arachidonic acid induced ﬁlaments [26] in part be-
cause C18H37SO4Na inducer yields longer length distributions
[23], and so fewer ﬁlament ends were available to mediate dis-
aggregation. The kapp value for htau40
T212E disaggregation
was 0.013 ± 0.003 h1, or 5.2 ± 1.3-fold smaller than kapp for
wild-type htau40 (Fig. 3). Converting kapp values to k as de-
scribed in Section 2 and estimating k+ from critical concentra-
tions and Eq. (1) yields the estimates of elementary kinetic
constants summarized in Table 1. These data indicate that
pseudophosphorylation at position 212 yields a k value
3.1-fold lower than that of wild-type htau40. Because this
change is accompanied by a 3-fold decrease in critical con-
centration [19], we conclude that the major eﬀect of pseud-
ophosphorylation at residue 212 on assembly kinetics is to
modulate the dissociation rate from ﬁlament ends.
3.4. Rate constants for the tau extension reaction
The critical concentrations and hence the free energy diﬀer-
ence between ﬁlamentous and free tau is similar to that be-
tween microtubules and tubulin (Table 1). However, there
are marked diﬀerences in the underlying elementary rate con-
stants. Globular polymerizing proteins such as actin and tubu-
lin have association rate constants typical of protein–protein
interactions (104–106 M1 s1; [31]), consistent with these
reactions being nearly diﬀusion limited. In contrast, k+ for
Table 1
Kinetic constants for the extension phase of protein aggregation
reactions
Protein Kcrit (M) k+ (M
1 s1) k (s
1) Reference
Htau40 2.0 · 106 570a 1.1 · 103 Herein; [19]
Htau40T212E 0.7 · 106 510a 3.4 · 104 Herein; [19]
Ab1-40 1 · 104 90 9 · 103 [37]b
Actin-barbed
end
1.2 · 107 1.2 · 107 1.4 [42]
Actin-pointed
end
6.2 · 107 1.3 · 106 0.8 [42]
Tubulin 5 · 106 2 · 106 10 [43]
aCalculated from estimated k and Kcrit values assuming a simple one
step binding model (Eq. (1)).
bEstimated in 0.1 M HCl.
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smaller, suggesting that other factors, such as local conforma-
tional adaptations, are rate limiting. Indeed, seeding of recom-
binant tau preparations with mature ﬁlaments is ineﬃcient in
the absence of exogenous ﬁbrillization promoters [22,32], sug-
gesting k+ for the ensemble of natively unfolded tau conforma-
tions is very small. The values estimated here reﬂect the
presence of anionic inducer, which may raise k+ substantially,
and account for observations that anionic surfaces can cata-
lyze protein ﬁbrillization reactions [33].
The dissociation rate constants for actin and tubulin poly-
mers are large and consistent with the need for rapid reversibil-
ity within the cell. In contrast, k for tau ﬁlaments is small,
being similar in magnitude (6103 s1) to constants typically
encountered in diﬀusion limited binding reactions with sub-
nanomolar aﬃnities. These data suggest that slow dissociation
rates are a major source of tau ﬁlament stability. Under near
physiological conditions in vitro, full-length htau40 dissociates
with a t1/2 of 10.5 min, whereas pseudophosphorylation mu-
tant htau40T212E dissociates with a t1/2 of 34 min. Thus, the
data presented herein indicate that tau ﬁlament stability can
be modulated by pseudophosphorylation.
Although, the estimated dissociation rate constants are accu-
rate for purposes of comparison among htau40 constructs,
their absolute values are predicted to vary with conditions.
First, the precise mechanism through which N744 raises criti-
cal concentration is unknown, and its presence may inﬂuence
estimates in ways that are not obvious. Second, the ﬁlaments
formed over the course of these experiments are untwisted
and correspond to one hemiﬁlament of authentic paired-helical
ﬁlament (PHF) [22,27]. Mature PHF have twice the mass-per-
unit length of synthetic hemiﬁlaments [27], contain all six
isoforms [34], and may correspond to a minimum energy con-
formation achieved over long time periods [35,36]. Despite
these caveats, mathematical simulations of b-amyloid aggrega-
tion under non-physiological conditions estimated k and k+
values of similar magnitude as those estimated here for tau
[37]. These data indicate that a general pattern of weak associ-
ation and dissociation rate constants may be common to amy-
loid ﬁlaments of diﬀering morphologies and compositions.
3.5. Molecular mechanism
The principal forces modulating protein ﬁbrillization report-
edly include b-structure content, hydrophobicity, net charge
(isoelectric point), and p stacking interactions [38–41]. In thecase of tau protein, phosphorylation of Ser/Thr residues lowers
its isoelectric point and net charge at physiological pH, both of
which are predicted to lower solubility and increase rates of
aggregation [38]. Fitting aggregation data to a monomolecular
growth function assuming a simple two-state model yielded a
highly signiﬁcant correlation between kapp, an apparent pseu-
do-ﬁrst order growth rate constant, and net charge [41]. Under
these experimental conditions, apparent growth rates incorpo-
rated both nucleation and extension phases of aggregation,
and so it was not possible to directly link charge-associated
modulation of assembly kinetics to either. We ﬁnd that pseud-
ophosphorylation can increase growth rates, but that its eﬀect
on tau aggregation kinetics is site speciﬁc [19]. These data sug-
gest that local interactions in addition to changes in isoelectric
point are important in the tau aggregation reaction.
In summary, incorporation of negative charge into speciﬁc
tau phosphorylation sites can have signiﬁcant eﬀects on aggre-
gation kinetics by acting at the level of ﬁlament extension. The
mechanism may be especially important at early stages of
disease.
Acknowledgements: We thank Mike Zhu, Ohio State University Cen-
ter for Molecular Neurobiology, for assistance with ﬂuorescence mea-
surements. This work was supported by grants from the National
Institutes of Health (AG14452) and the Alzheimers Association
(RG2-29-076).References
[1] Brandt, R., Hundelt, M. and Shahani, N. (2005) Tau alteration
and neuronal degeneration in tauopathies: mechanisms and
models. Biochim. Biophys. Acta 1739, 331–354.
[2] Ghoshal, N., Garcia-Sierra, F., Wuu, J., Leurgans, S., Bennett,
D.A., Berry, R.W. and Binder, L.I. (2002) Tau conformational
changes correspond to impairments of episodic memory in mild
cognitive impairment and Alzheimers disease. Exp. Neurol. 177,
475–493.
[3] Royall, D.R., Palmer, R., Mulroy, A.R., Polk, M.J., Roman,
G.C., David, J.P. and Delacourte, A. (2002) Pathological deter-
minants of the transition to clinical dementia in Alzheimers
disease. Exp. Aging Res. 28, 143–162.
[4] Kopke, E., Tung, Y.C., Shaikh, S., Alonso, A.C., Iqbal, K. and
Grundke-Iqbal, I. (1993) Microtubule-associated protein tau.
Abnormal phosphorylation of a non-paired helical ﬁlament pool
in Alzheimer disease. J. Biol. Chem. 268, 24374–24384.
[5] Ksiezak-Reding, H., Liu, W.K. and Yen, S.H. (1992) Phosphate
analysis and dephosphorylation of modiﬁed tau associated with
paired helical ﬁlaments. Brain Res. 597, 209–219.
[6] Biernat, J., Gustke, N., Drewes, G., Mandelkow, E.M. and
Mandelkow, E. (1993) Phosphorylation of Ser262 strongly
reduces binding of tau to microtubules: distinction between
PHF-like immunoreactivity and microtubule binding. Neuron 11,
153–163.
[7] Bramblett, G.T., Goedert, M., Jakes, R., Merrick, S.E., Troja-
nowski, J.Q. and Lee, V.M. (1993) Abnormal tau phosphoryla-
tion at Ser396 in Alzheimers disease recapitulates development
and contributes to reduced microtubule binding. Neuron 10,
1089–1099.
[8] Matsuo, E.S., Shin, R.W., Billingsley, M.L., Van deVoorde, A.,
OConnor, M., Trojanowski, J.Q. and Lee, V.M. (1994) Biopsy-
derived adult human brain tau is phosphorylated at many of the
same sites as Alzheimers disease paired helical ﬁlament tau.
Neuron 13, 989–1002.
[9] Seubert, P., et al. (1995) Detection of phosphorylated Ser262 in
fetal tau, adult tau, and paired helical ﬁlament tau. J. Biol. Chem.
270, 18917–18922.
[10] Kenessey, A. and Yen, S.H. (1993) The extent of phosphorylation
of fetal tau is comparable to that of PHF-tau from Alzheimer
paired helical ﬁlaments. Brain Res. 629, 40–46.
M. Necula, J. Kuret / FEBS Letters 579 (2005) 1453–1457 1457[11] Alonso, A., Zaidi, T., Novak, M., Grundke-Iqbal, I. and Iqbal,
K. (2001) Hyperphosphorylation induces self-assembly of tau into
tangles of paired helical ﬁlaments/straight ﬁlaments. Proc. Natl.
Acad. Sci. USA 98, 6923–6928.
[12] Schneider, A., Biernat, J., von Bergen, M., Mandelkow, E. and
Mandelkow, E.M. (1999) Phosphorylation that detaches tau
protein from microtubules (Ser262, Ser214) also protects it
against aggregation into Alzheimer paired helical ﬁlaments.
Biochemistry 38, 3549–3558.
[13] Leger, J., Kempf, M., Lee, G. and Brandt, R. (1997) Conversion
of serine to aspartate imitates phosphorylation-induced changes
in the structure and function of microtubule-associated protein
tau. J. Biol. Chem. 272, 8441–8446.
[14] Eidenmuller, J., Fath, T., Hellwig, A., Reed, J., Sontag, E. and
Brandt, R. (2000) Structural and functional implications of tau
hyperphosphorylation: information from phosphorylation-mim-
icking mutated tau proteins. Biochemistry 39, 13166–13175.
[15] Eidenmuller, J., Fath, T., Maas, T., Pool, M., Sontag, E. and
Brandt, R. (2001) Phosphorylation-mimicking glutamate clusters
in the proline-rich region are suﬃcient to simulate the functional
deﬁciencies of hyperphosphorylated tau protein. Biochem. J. 357,
759–767.
[16] Fath, T., Eidenmuller, J. and Brandt, R. (2002) Tau-mediated
cytotoxicity in a pseudohyperphosphorylation model of Alzhei-
mers disease. J. Neurosci. 22, 9733–9741.
[17] Haase, C., Stieler, J.T., Arendt, T. and Holzer, M. (2004)
Pseudophosphorylation of tau protein alters its ability for self-
aggregation. J. Neurochem. 88, 1509–1520.
[18] Chirita, C.N. and Kuret, J. (2004) Evidence for an intermediate in
tau ﬁlament formation. Biochemistry 43, 1704–1714.
[19] Necula, M. and Kuret, J. (2004) Pseudophosphorylation and
glycation of tau protein enhance but do not trigger ﬁbrillization in
vitro. J. Biol. Chem. 279, 49694–49703.
[20] Timasheﬀ, S.N. (1981) in: Protein–protein Interactions (Nichol,
L.W., Ed.), pp. 315–336, Wiley, New York.
[21] Carmel, G., Mager, E.M., Binder, L.I. and Kuret, J. (1996) The
structural basis of monoclonal antibody Alz50s selectivity for
Alzheimers disease pathology. J. Biol. Chem. 271, 32789–32795.
[22] King, M.E., Ahuja, V., Binder, L.I. and Kuret, J. (1999) Ligand-
dependent tau ﬁlament formation: implications for Alzheimers
disease progression. Biochemistry 38, 14851–14859.
[23] Chirita, C.N., Necula, M. and Kuret, J. (2003) Anionic Micelles
and Vesicles induce tau ﬁbrillization in vitro. J. Biol. Chem. 278,
25644–25650.
[24] Kristoﬀerson, D., Karr, T.L. and Purich, D.L. (1980) Dynamics
of linear protein polymer disassembly. J. Biol. Chem. 255, 8567–
8572.
[25] Karr, T.L., Kristoﬀerson, D. and Purich, D.L. (1980) Mechanism
of microtubule depolymerization. Correlation of rapid induced
disassembly experiments with a kinetic model for endwise
depolymerization. J. Biol. Chem. 255, 8560–8566.
[26] Chirita, C.N., Necula, M. and Kuret, J. (2004) Ligand-dependent
inhibition and reversal of tau ﬁlament formation. Biochemistry
43, 2879–2887.[27] King, M.E., Ghoshal, N., Wall, J.S., Binder, L.I. and Ksiezak-
Reding, H. (2001) Structural analysis of Picks disease-derived
and in vitro-assembled tau ﬁlaments. Am. J. Pathol. 158, 1481–
1490.
[28] King, M.E., Gamblin, T.C., Kuret, J. and Binder, L.I. (2000)
Diﬀerential assembly of human tau isoforms in the presence of
arachidonic acid. J. Neurochem. 74, 1749–1757.
[29] Necula, M. and Kuret, J. (2004) Electron microscopy as a
quantitative assay for studying tau ﬁbrillization. Anal. Biochem.
329, 238–246.
[30] Craig, D.A. (1993) The Cheng–Prusoﬀ relationship: something
lost in the translation. Trends Pharmacol. Sci. 14, 89–91.
[31] Schlosshauer, M. and Baker, D. (2004) Realistic protein–protein
association rates from a simple diﬀusional model neglecting long-
range interactions, free energy barriers, and landscape ruggedness.
Protein Sci. 13, 1660–1669.
[32] Friedhoﬀ, P., von Bergen, M., Mandelkow, E.M., Davies, P. and
Mandelkow, E. (1998) A nucleated assembly mechanism of
Alzheimer paired helical ﬁlaments. Proc. Natl. Acad. Sci. USA 95,
15712–15717.
[33] Zhu, M., Souillac, P.O., Ionescu-Zanetti, C., Carter, S.A. and
Fink, A.L. (2002) Surface-catalyzed amyloid ﬁbril formation.
J. Biol. Chem. 277, 50914–50922.
[34] Goedert, M., Spillantini, M.G., Jakes, R., Rutherford, D. and
Crowther, R.A. (1989) Multiple isoforms of human microtubule-
associated protein tau: sequences and localization in neuroﬁbril-
lary tangles of Alzheimers disease. Neuron 3, 519–526.
[35] Turner, M.S., Briehl, R.W., Ferrone, F.A. and Josephs, R. (2003)
Twisted protein aggregates and disease: the stability of sickle
hemoglobin ﬁbers. Phys. Rev. Lett. 90, 128103.
[36] Callahan, L.M. and Coleman, P.D. (1995) Neurons bearing
neuroﬁbrillary tangles are responsible for selected synaptic deﬁcits
in Alzheimers disease. Neurobiol. Aging 16, 311–314.
[37] Lomakin, A., Teplow, D.B., Kirschner, D.A. and Benedek, G.B.
(1997) Kinetic theory of ﬁbrillogenesis of amyloid beta-protein.
Proc. Natl. Acad. Sci. USA 94, 7942–7947.
[38] Chiti, F., Stefani, M., Taddei, N., Ramponi, G. and Dobson,
C.M. (2003) Rationalization of the eﬀects of mutations on peptide
and protein aggregation rates. Nature 424, 805–808.
[39] Gazit, E. (2002) A possible role for pi-stacking in the self-
assembly of amyloid ﬁbrils. FASEB J. 16, 77–83.
[40] Schmittschmitt, J.P. and Scholtz, J.M. (2003) The role of protein
stability, solubility, and net charge in amyloid ﬁbril formation.
Protein Sci. 12, 2374–2378.
[41] Calamai, M., Taddei, N., Stefani, M., Ramponi, G. and Chiti, F.
(2003) Relative inﬂuence of hydrophobicity and net charge in the
aggregation of two homologous proteins. Biochemistry 42,
15078–15083.
[42] Pollard, T.D., Blanchoin, L. and Mullins, R.D. (2000) Molecular
mechanisms controlling actin ﬁlament dynamics in non-muscle
cells. Ann. Rev. Biophys. Biomol. Struct. 29, 545–576.
[43] Hall, D. (2003) The eﬀects of Tubulin denaturation on the
characterization of its polymerization behavior. Biophys. Chem.
104, 655–682.
